Suchergebnisse - "Gadgeel, Shirish"

PubPharm (50)

1

A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

enthalten in: Clinical lung cancer | 2024

von Qin, A. | Wells, L. | Malhotra, B. | +5

2

Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2024

von Drilon, A. | Camidge, D. | Lin, J. | +131

3

MRTX-500 Phase 2 Trial : Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von He, K. | Berz, D. | Gadgeel, S. | +17

4

Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation

enthalten in: The New England journal of medicine | 2022

von Jänne, P. | Riely, G. | Gadgeel, S. | +19

CommentIn: N Engl J Med. 2022 Jul 14;387(2):180-183. - PMID 35830645

5

Continuation of Lorlatinib in ALK-Positive NSCLC Beyond Progressive Disease

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Ou, S. | Solomon, B. | Shaw, A. | +7

CommentIn: J Thorac Oncol. 2022 Sep;17(9):e85-e86. - PMID 36031298

6

Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2022

von Li, B. | Smit, E. | Goto, Y. | +43

CommentIn: Nat Rev Clin Oncol. 2021 Dec;18(12):748. - PMID 34611335

7

Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC : Initial Results of the Phase 2 ALK-Positive Cohort

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Dziadziuszko, R. | Mok, T. | Peters, S. | +22

8

Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial

enthalten in: Cancer discovery | 2021

von Riely, G. | Neal, J. | Camidge, D. | +19

CommentIn: Cancer Discov. 2021 Jul;11(7):1617-1619. - PMID 34284994

9

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW) : a multi-cohort, open-label, phase 1/2 study

enthalten in: The Lancet. Oncology | 2021

von Gainor, J. | Curigliano, G. | Kim, D. | +22

ErratumIn: Lancet Oncol. 2021 Aug;22(8):e347. - PMID 34339651

10

Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC : Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Mazieres, J. | Rittmeyer, A. | Gadgeel, S. | +8

1
2
3
4
5
Nächster »
[5]